首页> 外文期刊>British Journal of Clinical Pharmacology >Stereoselective glucuronidation of formoterol by human liver microsomes.
【24h】

Stereoselective glucuronidation of formoterol by human liver microsomes.

机译:人肝微粒体对福莫特罗的立体选择性葡糖醛酸苷化作用。

获取原文
获取原文并翻译 | 示例
       

摘要

AIMS: Formoterol is a beta2-adrenoceptor agonist marketed as a racemic mixture of the active (R; R)- and inactive (S; S)-enantiomers (rac-formoterol). The drug produces prolonged bronchodilation by inhalation but there is significant interpatient variability in duration of effect. Previous work has shown that in humans formoterol is metabolized by conjugation with glucuronic acid but little is known about the stereoselectivity of this reaction. The aim of the present study was to investigate the glucuronidation of formoterol enantiomers in vitro by human liver microsomes. METHODS: The kinetics of formation of formoterol glucuronides during incubation of racemate and of single formoterol enantiomers with human liver microsomes (n=9) was characterized by chiral h.p.l.c. assay. RESULTS: The kinetics of glucuronidation of the two formoterol enantiomers obeyed the Michaelis-Menten equation. Glucuronidation of formoterol was stereoselective and occurred more than two times faster for (S; S)-formoterol than for (R; R)-formoterol. In incubations with single formoterol enantiomers, the median (n=9) Km values for (R; R)-glucuronide and (S; S)-glucuronide were 827.6 and 840.4 &mgr;m, respectively, and the median V max values were 2625 and 4304 pmol min-1 mg-1, respectively. Corresponding values determined in incubations with rac-formoterol were 357.2 and 312.1 &mgr;m and 1435 and 2086 pmol min-1 mg-1 for (R; R)- and (S; S)-glucuronide, respectively. Interindividual variation was large with the ratio of V max/Km (S; S/R; R) ranging from 0.57 to 6.90 for incubations with rac-formoterol. CONCLUSIONS: Our study demonstrates that glucuronidation of formoterol by human liver microsomes is stereoselective and subject to high interindividual variability. These findings suggest that clearance of formoterol in humans is subject to variable stereoselectivity which could explain the variation in duration of bronchodilation produced by inhaled formoterol in patients with asthma.
机译:目的:福莫特罗是一种β2-肾上腺素受体激动剂,以活性(R; R)-和非活性(S; S)对映异构体(rac-formoterol)的外消旋混合物形式销售。该药物可通过吸入产生延长的支气管扩张作用,但患者之间的持续时间差异很大。先前的研究表明,福莫特罗在人体中通过与葡萄糖醛酸的结合而被代谢,但对该反应的立体选择性知之甚少。本研究的目的是研究人肝微粒体在体外对福莫特罗对映异构体的葡萄糖醛酸化作用。方法:通过手性h.p.l.c表征外消旋物和单个福莫特罗对映体与人肝微粒体(n = 9)孵育期间形成福莫特罗葡萄糖醛酸的动力学。分析。结果:两种福莫特罗对映体的葡萄糖醛酸化动力学符合Michaelis-Menten方程。福莫特罗的葡萄糖醛酸化是立体选择性的,并且(S; S)-福莫特罗的发生速度是(R; R)-福莫特罗的两倍。在与单一福莫特罗对映体的孵育中,(R; R)-葡糖醛酸苷和(S; S)-葡糖醛酸苷的中值(n = 9)Km值分别为827.6和840.4μm,中值V max值为2625和4304 pmol min-1 mg-1。 (R; R)-和(S; S)-葡糖醛酸苷在与rac-formoterol一起温育中确定的相应值分别为357.2和312.1μm,以及1435和2086pmol min-1 mg-1。与rac-formoterol一起孵育时,个体间差异很大,V max / Km(S; S / R; R)的比在0.57至6.90之间。结论:我们的研究表明,人肝微粒体对福莫特罗的葡糖醛酸具有立体选择性,且个体间差异较大。这些发现表明,福莫特罗在人体内的清除具有可变的立体选择性,这可以解释哮喘患者吸入福莫特罗产生的支气管扩张持续时间的变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号